ATE184005T1 - Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung - Google Patents

Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung

Info

Publication number: ATE184005T1
Authority: AT; Austria
Prior art keywords: preparation; therapeutic use; oxazolidinone derivatives; oxazolidinone; derivatives
Prior art date: 1995-06-02

Application number

AT96918719T

Other languages

English (en)

Inventor

Samir Jegham

Frederic Puech

Philippe Burnier

Original Assignee

Synthelabo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-02

Filing date

1996-05-28

Publication date

1999-09-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26232004&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE184005(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-06-02 Priority claimed from FR9506564A external-priority patent/FR2734821B1/fr

1995-06-02 Priority claimed from FR9506563A external-priority patent/FR2734820B1/fr

1996-05-28 Application filed by Synthelabo filed Critical Synthelabo

1999-09-15 Application granted granted Critical

1999-09-15 Publication of ATE184005T1 publication Critical patent/ATE184005T1/de

Links

IZXIZTKNFFYFOF-UHFFFAOYSA-N 2-Oxazolidone Chemical class O=C1NCCO1 IZXIZTKNFFYFOF-UHFFFAOYSA-N 0.000 title 1
230000001225 therapeutic effect Effects 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

AT96918719T 1995-06-02 1996-05-28 Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung ATE184005T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9506564A FR2734821B1 (fr)	1995-06-02	1995-06-02	Derives de 5-methoxymethyl-3-(1,2-benzisoxazol-3-yl) oxazolidin-2-one, leur preparation et leur application en therapeutique
FR9506563A FR2734820B1 (fr)	1995-06-02	1995-06-02	Derives de 3-(1,2-benzisoxazol-3-yl)oxazolidin-2-one, leur preparation et leur application en therapeutique

Publications (1)

Publication Number	Publication Date
ATE184005T1 true ATE184005T1 (de)	1999-09-15

Family

ID=26232004

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96918719T ATE184005T1 (de)	1995-06-02	1996-05-28	Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung

Country Status (26)

Country	Link
US (1)	US5843975A (de)
EP (1)	EP0835254B1 (de)
JP (1)	JP3856829B2 (de)
KR (1)	KR100457502B1 (de)
CN (1)	CN1075072C (de)
AR (1)	AR006301A1 (de)
AT (1)	ATE184005T1 (de)
AU (1)	AU699367B2 (de)
BR (1)	BR9608896A (de)
CA (1)	CA2223011C (de)
CO (1)	CO4700462A1 (de)
CZ (1)	CZ378497A3 (de)
DE (1)	DE69604071T2 (de)
DK (1)	DK0835254T3 (de)
ES (1)	ES2138346T3 (de)
GR (1)	GR3031710T3 (de)
HU (1)	HU224879B1 (de)
MX (1)	MX9709410A (de)
NO (1)	NO309091B1 (de)
NZ (1)	NZ310487A (de)
PL (1)	PL183919B1 (de)
RU (1)	RU2164226C2 (de)
SK (1)	SK281934B6 (de)
TW (1)	TW360654B (de)
WO (1)	WO1996038444A1 (de)
ZA (1)	ZA964563B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1078632A1 (de) *	1999-08-16	2001-02-28	Sanofi-Synthelabo	Verwendung von Monoamin Oxydase Inhibitoren zu Herstellung eines Medikaments zur Behandlung der Fettleibigkeit
CA2671776C (en) *	2001-01-31	2012-12-18	H. Lundbeck A/S	Gal3 receptor antagonists for the treatment of depression
TWI248438B (en) *	2001-04-10	2006-02-01	Sod Conseils Rech Applic	Derivatives of heterocycles with 5 members, their preparation and their use as medicaments
BR0212841A (pt) *	2001-09-26	2004-08-03	Pharmacia Italia Spa	Derivado ativo de aminoindazole como inibidores de cinase, processo para sua preparação e composições farmacêuticas que os contém
DE10334309A1 (de) *	2003-07-28	2005-03-03	Aventis Pharma Deutschland Gmbh	Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
CA2637811A1 (en) *	2006-02-01	2007-08-09	Pfizer Products Inc.	Benzisoxazole oxazolidinones as antibacterial agents
JPWO2008120655A1 (ja) *	2007-03-30	2010-07-15	株式会社医薬分子設計研究所	Ｉ型１１βヒドロキシステロイド脱水素酵素阻害活性を有するオキサゾリジノン誘導体
EP2123159A1 (de) *	2008-05-21	2009-11-25	Bayer CropScience AG	(1,2-Benzisothiazol-3-yl)(thio)carbamate und (1,2-Benzisothiazol-3-yl)(thio)oxamate und deren Oxidationsformen als Pestizide
AU2010330894A1 (en) *	2009-12-18	2012-07-05	Janssen Pharmaceutica Nv	Substituted aminothiazolone indazoles as estrogen related receptor-aalpha modulators
WO2011103130A1 (en) *	2010-02-17	2011-08-25	Janssen Pharmaceutica Nv	Aminothiazolones as estrogen related receptor-alpha modulators
WO2016097355A1 (en) *	2014-12-19	2016-06-23	Ge Healthcare Limited	Labelled oxazolidinone derivatives
DE102015012050A1 (de) *	2015-09-15	2017-03-16	Merck Patent Gmbh	Verbindungen als ASIC-Inhibitoren und deren Verwendungen
RU2637643C1 (ru) *	2016-09-05	2017-12-05	Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт фундаментальной и клинической иммунологии" (НИИФКИ)	Иммунодепрессант

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69021645T2 (de) *	1989-05-19	1996-02-22	Hoechst-Roussel Pharmaceuticals Inc., Somerville, N.J.	N-(aryloxyalkyl)heteroarylpiperidine und -heteroarylpiperazine, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikamente.
FR2653017B1 (fr) *	1989-10-17	1995-05-05	Delalande Sa	Derives d'aryl-3 oxazolidinone-2, leur procede de preparation et leur application en therapeutique.
US5196543A (en) *	1989-10-17	1993-03-23	Delalande S.A.	3-aryloxazolidinone derivatives, process for their preparation and their use in therapy
US5235063A (en) *	1989-10-17	1993-08-10	Delalande S.A.	Process of preparing by condensation certain
US5182296A (en) *	1989-10-26	1993-01-26	Tanabe Seiyaky Co., Ltd.	Naphthyloxazolidone derivatives
FR2671350A1 (fr) *	1991-01-08	1992-07-10	Adir	Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
WO1992014418A1 (en) *	1991-02-20	1992-09-03	Yusaku Koda	Articulator

1996
- 1996-05-28 KR KR1019970708666A patent/KR100457502B1/ko not_active Expired - Lifetime
- 1996-05-28 EP EP96918719A patent/EP0835254B1/de not_active Expired - Lifetime
- 1996-05-28 JP JP53624596A patent/JP3856829B2/ja not_active Expired - Lifetime
- 1996-05-28 NZ NZ310487A patent/NZ310487A/xx not_active IP Right Cessation
- 1996-05-28 DE DE69604071T patent/DE69604071T2/de not_active Expired - Lifetime
- 1996-05-28 AT AT96918719T patent/ATE184005T1/de active
- 1996-05-28 HU HU9901349A patent/HU224879B1/hu unknown
- 1996-05-28 SK SK1614-97A patent/SK281934B6/sk not_active IP Right Cessation
- 1996-05-28 CN CN96195713A patent/CN1075072C/zh not_active Expired - Lifetime
- 1996-05-28 PL PL96323673A patent/PL183919B1/pl unknown
- 1996-05-28 RU RU98100257/04A patent/RU2164226C2/ru active
- 1996-05-28 ES ES96918719T patent/ES2138346T3/es not_active Expired - Lifetime
- 1996-05-28 US US08/973,246 patent/US5843975A/en not_active Expired - Lifetime
- 1996-05-28 BR BR9608896A patent/BR9608896A/pt active IP Right Grant
- 1996-05-28 CA CA002223011A patent/CA2223011C/en not_active Expired - Lifetime
- 1996-05-28 WO PCT/FR1996/000792 patent/WO1996038444A1/fr not_active Ceased
- 1996-05-28 CZ CZ973784A patent/CZ378497A3/cs unknown
- 1996-05-28 AU AU61288/96A patent/AU699367B2/en not_active Expired
- 1996-05-28 DK DK96918719T patent/DK0835254T3/da active
- 1996-05-31 CO CO96028173A patent/CO4700462A1/es unknown
- 1996-06-01 TW TW085106564A patent/TW360654B/zh not_active IP Right Cessation
- 1996-06-03 AR ARP960102870A patent/AR006301A1/es active IP Right Grant
- 1996-06-03 ZA ZA964563A patent/ZA964563B/xx unknown
1997
- 1997-12-01 NO NO975530A patent/NO309091B1/no not_active IP Right Cessation
- 1997-12-02 MX MX9709410A patent/MX9709410A/es unknown
1999
- 1999-11-03 GR GR990402802T patent/GR3031710T3/el unknown

Also Published As

Publication number	Publication date
TW360654B (en)	1999-06-11
NZ310487A (en)	1999-05-28
CN1191534A (zh)	1998-08-26
BR9608896A (pt)	1999-06-29
CA2223011C (en)	2007-01-09
PL183919B1 (pl)	2002-08-30
NO975530D0 (no)	1997-12-01
CA2223011A1 (en)	1996-12-05
ZA964563B (en)	1996-12-12
AR006301A1 (es)	1999-08-25
CN1075072C (zh)	2001-11-21
DK0835254T3 (da)	2000-03-27
KR100457502B1 (ko)	2005-09-05
US5843975A (en)	1998-12-01
AU699367B2 (en)	1998-12-03
KR19990022187A (ko)	1999-03-25
CO4700462A1 (es)	1998-12-29
EP0835254B1 (de)	1999-09-01
WO1996038444A1 (fr)	1996-12-05
DE69604071D1 (de)	1999-10-07
HU224879B1 (en)	2006-03-28
HUP9901349A2 (hu)	1999-08-30
SK281934B6 (sk)	2001-09-11
HUP9901349A3 (en)	2000-02-28
JP3856829B2 (ja)	2006-12-13
AU6128896A (en)	1996-12-18
HK1014938A1 (en)	1999-10-08
CZ378497A3 (cs)	1998-04-15
NO309091B1 (no)	2000-12-11
GR3031710T3 (en)	2000-02-29
SK161497A3 (en)	1998-05-06
JPH11507330A (ja)	1999-06-29
DE69604071T2 (de)	2000-04-06
RU2164226C2 (ru)	2001-03-20
NO975530L (no)	1998-02-02
MX9709410A (es)	1998-07-31
EP0835254A1 (de)	1998-04-15
PL323673A1 (en)	1998-04-14
ES2138346T3 (es)	2000-01-01

Legal Events

Date	Code	Title	Description
2000-05-15	EEIH	Change in the person of patent owner
2000-05-15	UEP	Publication of translation of european patent specification

Publication	Publication Date	Title
ATE258549T1 (de)	2004-02-15	Oxazolidindion-derivate, ihre herstellung und verwendung
ATE224910T1 (de)	2002-10-15	Derivate von dolestatin, deren herstellung und verwendung
DE122008000020I1 (de)	2008-08-07	Disubstituierte bicyclische heterocyclen, ihre herstellung und ihre verwendung als arzneimittel
DE60001451T2 (de)	2004-01-15	1,4-diazabicyclo[3.2.2]nonan-4-carboxylat und carboxamidderivate, ihre herstellung und therapeutische verwendung
ATE259357T1 (de)	2004-02-15	Derivate von acyl-piperazinil-pyrimidinen, ihre herstellung und verwendung als medikament
ATE231869T1 (de)	2003-02-15	Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE69625857D1 (de)	2003-02-27	Siliconderivate, ihre Herstellung und Verwendung
DE69027170D1 (de)	1996-07-04	Uracilderivate, ihre Herstellung und ihre Verwendung
ATE218567T1 (de)	2002-06-15	1h-pyrido(3,4-b)indolcarboxamidderivate, ihre herstellung und therapeutische verwendung
FI956298A0 (fi)	1995-12-28	3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö
ATE184005T1 (de)	1999-09-15	Oxazolidinone derivate, ihre herstellung und ihre therapeutische verwendung
ATE202782T1 (de)	2001-07-15	Optisch-aktives benzothiepin-derivate, ihre herstellung und verwendung
DE59208576D1 (de)	1997-07-10	3-Isoxazolylphenylverbindungen, ihre Herstellung und ihre Verwendung
DE50002417D1 (de)	2003-07-10	3-Amino-3-arylpropan-1-ol-Derivate, deren Herstellung und Verwendung
DE69514398D1 (de)	2000-02-17	13-Substituierte Milbemycinderivate, ihre Herstellung und Verwendung
ATE212346T1 (de)	2002-02-15	3-substituierte tetrahydropyridopyrimidinon- derivate, ihre herstellung und verwendung
FI941068A7 (fi)	1994-09-09	Bentsoksatsiinijohdannaiset, niiden valmistus ja terapeuttinen käyttö
ATE226584T1 (de)	2002-11-15	4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- acetamid-derivate, ihre herstellung und therapeutische anwendung
ATE252096T1 (de)	2003-11-15	Prolylendopeptidase-inhibitoren, ihre herstellung und ihre pharmazeutische verwendung
DE69723463D1 (de)	2003-08-14	Cyclische organoselenderivate, ihre herstellung und verwendung
ATE198192T1 (de)	2001-01-15	Benzolsulfonamidderivate, ihre herstellung und ihre therapeutische verwendung
DE59501950D1 (de)	1998-05-28	Isolongifolanol-Derivate, ihre Herstellung und ihre Verwendung
ATE236905T1 (de)	2003-04-15	4-oxo-3,5-dihydro-4h-pyridazino(4,5-b)indol-1- carboxamid-derivate, ihre herstellung und therapeutische verwendung
ATE205841T1 (de)	2001-10-15	Derivate von 5-naphthalin-1-yl-1,3-dioxanen, ihre herstellung und therapeutische anwendung
ATE263138T1 (de)	2004-04-15	3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung